~" Tissue samples from 57 patients with neuroepithelial tumors (25 glioblastomas, 18 anaplastic astrocytomas, and 14 astrocytomas) were analyzed in order to evaluate the presence of estrogen, progesterone, glucocorticoid, and androgen receptors. Glucocorticoid-and androgen-specific binding proteins were present in 38.6% and 21.6% of the cases, respectively. Only a few tumors showed estrogen or progesterone receptors. A correlation was found between grade of anaplasia, patient's sex and age, and presence of glucocorticoid and androgen receptors. The biological role of these two receptors was investigated in 10 primary cell cultures derived from neuroepithelial tumors. For this purpose, dexamethasone and testosterone were added to culture medium at different concentrations (from 50 to 0.016 tzg/ml). A significant stimulation of the cell growth was observed in four of five glucocorticoid receptor-positive cultures when dexamethasone in doses ranging from 2 to 0.016 ~zg/ml was added to the culture. No modulation of the growth was observed in glucocorticoid receptor-negative cultures at the same doses. Higher dexamethasone doses induced a significant decrease of the growth index independently from the glucocorticoid receptor status. All of the cultures tested for testosterone activity were negative for androgen receptors. This hormone induced an inhibition of the growth index at doses ranging from 50 to 0.4 ug/ml. The data suggest that neuroepithelial tumors contain specific glucocorticoid and androgen binding proteins. Glucocorticoid receptors modulate the growth of cultured neuroepithelial tumors in the presence of different concentrations of dexamethasone.
A W1DE variety of physiological processes are controlled by steroid hormones. Their action on cell depends on the following conditions: 1) a specific intracellular receptor for the steroid hormone must be present to bind the hormone; 2) the steroid hormone level must be sufficiently high to bind to the receptor; and 3) the hormone responsive genes in the genome must be in a conformation that allows their regulation by the hormone-receptor complex. When this complex is formed, it translocates to the nucleus after activation. The activated complex interacts with the nuclear chromatin leading to protein synthesis and/ or cell duplication. TM This biological sequence has assumed important implications in the diagnosis and treatment of endocrinerelated tumors. For example, the presence of appreciable levels of estrogen and progesterone receptors in breast cancer suggests a potential hormone-sensitivity of the tumor, and a correlation between receptor amount and response to endocrine therapy has been described. 6A9 Based on epidemiological and clinical data, the hypothesis of hormonal influence on nervous system tumors has recently been investigated. Steroid hormone receptors have been detected in human meningiomas (especially progesterone receptors), 2'1~ and some attempts toward endocrine therapy of these tumors have been made. 4'8'12A7'2~ Neuroepithelial tumors (that is, astrocytoma, anaplastic astrocytoma, and glioblastoma) have been thought to express steroid hormone receptors at a low leveP 8 and data reported in the literature are scanty and controversial. 5'3"2~ ' 22" 25 Furthermore, no data have been available until now on the biological role of these receptors in these tumors. In the present paper, we have analyzed a large series of neuroepithelial tumors, evaluating the presence of estrogen, progesterone, glucocorticoid, and androgen receptors. Furthermore, we have described the biological role of glucocorticoid and androgen receptors in primary cell cultures derived from human neuroepithelial tumors.
Materials and Methods

Steroid Hormone Receptor Determination on Tumor Tissue
Tissue samples of neuroepithelial tumors were obtained during surgery from 57 unselected patients. The tumors included 25 glioblastomas, 18 anaplastic astrocytomas, and 14 astrocytomas (Table 1 ). In addition, seven samples of normal brain tissue (five from frontallobe and two from temporal-lobe white matter) were obtained from patients who underwent lobectomy for the removal of tumor. All of the patients received dexamethasone at a dose ranging from 8 to 24 mg/day for a variable period of time preoperatively.
The specimens for the hormone binding assay were immediately frozen in liquid nitrogen and then stored at -80~ until the time of study. Adjacent samples were taken for histological examination. At the time of assay the frozen tissues were minced with surgical scissors and weighed. They were homogenized in a phosphate buffer (10 mM sodium phosphate, pH 7.4, 1.5 mM (ethytenediaminetetra-acetic acid (EDTA), 10 mM monothioglycerol, 20 mM sodium molybdate, and 10% v/v glycerol) with three 10-second bursts of a homogenizer. The homogenate was spun at 105,000 G for l hour at 0 ~ to 4~ in an ultracentrifuge, The protein content of the cytosol was determined using the method of Lowry, et al., ~4 in order to obtain a protein dilution of approximately 2 mg/ml. Saturation analysis was performed by incubating duplicate samples of cytosol (200 vl) with increasing concentrations of labeled ligands. Tritiated estradiol (0.05 to 5 nM) was used for estrogen receptor determination in the presence or absence of an excess of diethylstilbestrol, and 3H-labeled ORG 2058 (0.05 to 5 nM) was used for progesterone receptor determination in the presence or absence of an excess of the equivalent unlabeled steroid. Tritiated-dexamethasone (1.0 to 30 nM) was used for glucocorticoid receptor determination in the presence or absence of an excess of the equivalent unlabeled steroid. Tritiated R1881 (0.1 to l0 nM) plus a 500-fold excess of triamcinolone acetonide was used for androgen receptor determination in the presence or absence of an excess of the equivalent unlabeled steroid.
After overnight incubation at 0 ~ to 4~ the mixtures were treated with 400 ~tl of dextran-coated charcoal (DCC) solution (final concentration: 0.5% Norite-A activated charcoal, 0.05% dextran) for l0 minutes at 4~ They were then centrifuged at 3500 G for l0 minutes. An aliquot of the supernatant was added to 10 ml of Insta Gel and the radioactivity was measured, The counting efficiency was approximately 38%. Scatchard plots were constructed for the binding data to determine the dissociation constants (Kd's).
The receptor binding sites are expressed as femtomoles of receptor per milligram of cytosol protein (fmot/mg protein), The arbitrary cut-off value of more than 10 fmol/mg protein was considered to be indicative of a positive receptor value. Results were statistically compared using Student's t-test.
Cell Culture
Neoplastic specimens from 10 other patients (Table  2) were obtained at surgery. Each tumor sample was divided into three portions. The first was examined histologically, the second was immediately frozen in liquid nitrogen and then stored at -80~ until binding studies were performed, and the last was placed in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), and sent to the tissue-culture laboratory.
The fragments of tumor were minced and incubated with trypsin (0.05%) and EDTA (0.02%) for a few minutes at 37~ after a wash in saline. The resulting cell suspension was centrifuged, the supernatant decanted, and the cell pellet resuspended in the medium indicated above and cultured into 25-sq cm tissue flasks. The flasks were then kept in a humidified 5% CO2 atmosphere.
The medium was decanted and replaced with fresh medium after 3 days; this procedure was repeated twice a week until the cell cultures were confluent. Cells were then trypsinized and replated until an adequate number was available for cell growth experiments and steroid receptor determination.
For the cell growth experiments, cells were trypsinized and the suspension was passed through a fine sterile needle to obtain single viable cells. They were seeded at an initial density of 5 • 103 or 10 • I0 ~ cells/ml in 96-well flat-bottom tissue culture plates. Cell suspension (100 ul) was added to each well and the plates were incubated at 37*C in a humidified 5% COz atmosphere for 72 hours. The medium was then removed from the test plates and replaced with 100 t~l of medium in the presence or absence of different concentrations of dexamethasone and testosterone (50, 10, 2, 0.4, 0.08, or 0.016 zg/ml).
Nine cultures were tested for dexamethasone activity (Cases 1 to 9) and eight (Cases 1 to 6, 9, and 10) for testosterone activity. The medium was changed 2 days later; plates were fixed with methanol and stained with Giemsa 10% after 4 days; each well was then counted microscopically. As reported by Jay, et al./2 and as observed in our preliminary studies, cell concentrations of less than 250 cells/weU were ideal for microscopic counting. The mean number of cells per well (seven wells for the control preparation and seven for each treatment) was then calculated and values were reported as percentage of controls (growth index). Student's ttest was applied for statistical analysis. 
Steroid Hormone Receptor Determination on Cell Culture
Glucocorticoid and androgen receptors were evaluated in nine and eight cultures, respectively, by wholecell assay. Ceils were seeded at an initial density of 5 x 105 cells/well in a 6-well tissue culture cluster and incubated in a humidified 5% CO2 atmosphere for 3 days. The medium was then changed with a new one supplemented with 10% DCC-FCS (FCS with 0.25% (w/v) Norite-A activated charcoal for t6 hours followed by ultracentrifugation and passage through a 0.22-um filter). Twenty-four hours later, cells were placed at 37"C for 15 minutes with RPMI 1640 without serum to remove most of the endogenous hormone and serum binding globulins.
Wells were incubated in duplicate, for 50 minutes, with 1 ml medium/dish containing the radiolabeled tracer (3H-dexamethasone, (specific activity: 70 to 110 Ci/mmol) and 3H-R1881 methyltrienolone (specific activity: 70 to 87 Ci/mmol) for glucocorticoid and androgen receptor determination, respectively), in the presence or absence of a 200-fold molar excess of unlabeled hormone. In the androgen receptor assay a 500-fold molar excess of triamcinolone acetonide was added to avoid binding of 3H-R1881 to progesterone without affecting androgen binding. The medium was removed after incubation and the wells were washed five times with cold physiological saline solution. Radioactivity was extracted using 1 ml of NaOH 1 M and counted with the addition of 4 ml of scintillation fluid. The results are expressed as fmol/mg deoxyribonucleic acid (DNA)) The arbitrary cut-off value of more than 1 fmol/mg DNA was considered to be indicative of a positive receptor value.
Results
Steroid Hormone Receptor Determination
The range of Kd values of the different receptors was as follows: progesterone receptors 0.1 to 0.9 nM; androgen receptors 0.1 to 0.9 nM; glucocorticoid receptors 2 to 7 nM; and estrogen receptors 0.5 to 0.7 nM. The results of the receptor content determinations are shown in Table 3 . Specific dexamethasone-binding proteins were detected in 22 of 57 samples while androgen receptors were present in 11 of 51 samples. Only a few tumor samples showed estrogen and progesterone receptor positivity (five and two samples, respectively). No steroid receptor positivity was observed in the seven samples of normal brain tissue (data not shown).
In our series, steroid receptor positivity is significantly influenced by sex (p < 0.02 for glucocorticoid receptors, and p < 0.005 for androgen receptors) ( Table  4) . In fact, a higher percentage of positivity is observed in females than in males. It is remarkable that all but one of the patients presenting specific androgen-binding proteins belong to the female group. This group was divided into three classes of age on the basis of the menopausal status (< 45, 45-55, > 55 years). Of the androgen receptor-positive cases, 61.5 % were older than 55 years, while glucocorticoid and estrogen receptor positivity is equally distributed in all groups (data not shown). Table 5 shows the correlation between steroid receptor positivity and tumor histological subtypes. Specific glucocorticoid binding proteins are present in one-half of the astrocytomas examined, and the percentage of positivity of this receptor decreases in relation to the increase of histological malignancy. An opposite trend is evident when androgen receptors are considered.
Influence of Glucocorticoid and Androgen Receptors on Cell Growth
The results of glucocorticoid and androgen receptor determinations are qualitatively similar both in tumor tissue and in cell cultures ( Table 6 ). Five of nine cultures showed levels of glucocorticoid receptors above the cutoff value. Table 7 shows the results of dexamethasone activity on cultures both positive and negative for glucocorticold receptor. A significant inhibition of the cell growth after treatment with 50 ug/ml of dexamethasone is evident in all of the cultures, and this is independent from the specific receptor status, Drug concentrations ranging from 2 to 0.016 ug/ml induced a significant enhancement of cell proliferation in four of the five glucocorticoid receptor-positive cultures. The growth of the receptor-negative cultures is not influenced by dexamethasone treatment at these doses.
The presence or the absence of the hormone binding proteins caused a statistically significant difference in growth index at 0.08 and 0.016 ug/ml of dexamethasone when the cultures are considered all together (Fig.  1) . A receptor-independent inhibition of growth index may be clearly seen with doses of 2 ug/ml or greater in receptor-negative cultures. The same effect is evident in receptor-positive cultures at 50 ug/ml. However, we may assume that, in glucocorticoid receptor-positive cell cultures at doses of 2 ~g/ml or greater, both receptor-mediated stimulatory effect and receptor-mediated inhibitory effect are present and acting antagonistically on the growth index. The results of testosterone activity assay on cell culture growth are shown in Table 8 . Specific androgenbinding proteins were not detected in any of the eight cases tested. Addition of 50 or 10 ~g/ml testosterone caused a marked and significant cytotoxic effect in all of the tumors. Growth inhibition was also present at the concentration of 2 ug/ml in seven tumors. No significant drug action was noted at the testosterone concentration of 0.08 or 0.016 ~g/ml except for Case 5, in which inhibition was still present.
Discussion
Historical Review
The presence of specific steroid hormone binding proteins is correlated with a clinical response to hormonal therapy in about 70% of patients with breast cancer.~ 1 Thus, hormonal manipulation of these tumors is considered a valuable therapeutic strategy. Studies on the determination of specific steroid hormone-binding proteins in intracranial tumors have previously been reported in the literature. Meningioma has been the oncotype most extensively examined; nevertheless, the P. P a o l e t t i , et al.
results have shown frequent discrepancies in most seties. 2'~5 The detection of specific steroid-binding proteins and results obtained with in vitro functional assays have suggested hormonal therapy for human meningiomas. Attention has focused on the presence of progesterone-and estrogen-binding proteins and on the modification induced by specific hormones (progesterone and estradiol) or antihormone drugs (RU-38486, tamoxifen, and medroxyprogesterone acetate) on meningioma cell g r o w t h . 8'~2'17'2~ The presence of androgen and glucocorticoid receptors has been studied in only a few reports, ~3' 2Lz2' 26 and the functional significance of these receptors in brain tumors has not yet been tested.
Receptor Content in Neuroepithelial Tumors
Studies on the expression of steroid hormone receptors in neuroepithelial tumors have seldom been reported. 3"1L1821' 22' 25' 26 We have examined four steroid hormone receptors (glucocorticoid, estrogen, progesterone, and androgen receptors) in these tumors in a series of patients that is one of the largest presented in the literature. We believe that strict criteria have been adopted in the evaluation of receptor positivity. Our studies have demonstrated that glucocorticoid and androgen receptors are the steroid hormone binding proteins observed most frequently in neuroepithelial tumors, while estrogen and progesterone receptors were seldom identified.
The relationship between glucocorticoid receptors, androgen receptors, and the grade of anaplasia is worth noting. The glucocorticoid receptor was more frequently found in low-grade astrocytomas. Glioblastomas showed androgen receptor positivity more often than did low-grade astrocytomas. We were not able to detect specific steroid binding activity in our control studies of human brain white matter under the same experimental conditions. We are now investigating whether receptor expression is dependent on neoplastic transformation or if the presence of the receptor is necessary for tumor development. Furthermore, it is noticeable that specific androgen binding proteins are 
Receptor Modulation of Cell Growth
After demonstrating the presence of specific steroid hormone-binding proteins, we investigated whether glucocorticoid and androgen hormones could have some effect on cell growth and whether these effects could be related to the presence of specific receptors in cultures derived from neuroepithelial tumors. Dexamethasone has been previously reported to act on the growth of cultured neuroepithelial tumors 9 but no relationship between the growth modulation and the presence of specific receptors has been described. Furthermore, high-dose corticosteroid (methylprednisolone) treatment was adopted after surgery and radiotherapy in a randomized study of the Brain Tumor Study Group. This treatment failed to improve survival time even in association with 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) chemotherapy. 7 We studied early-passage cultured cells in this research because cell lines may not be representative of the biological features of the original tumor. It is interesting to note that the receptor status of tumor specimens was maintained in cell cultures.
The inhibition of cell growth obtained after treatment with high doses of both androgen and glucocorticoid hormones is probably not due to receptor mediation, but seems to be related to other mechanisms (cell membrane alterations), as reported for other hormones, z4 Lower concentrations of dexamethasone stimulate growth only in glucocorticoid-positive tumors, so that this stimulation appears to be induced by the presence of the specific receptor. The absence of this drug activity in a glucocorticoid receptor-positive case could be explained considering that, as in breast cancer, the receptor presence is necessary but probably not sufficient to modulate growth. The importance of the presence of the specific receptor for growth modulation is enhanced by the absence of response in the glucocorticoid-negative cases.
This hypothesis was confirmed in the testosterone activity studies. Low drug concentrations of this hormone are ineffective on all of the androgen receptornegative cases.
Our observations indicate that dexamethasone and testosterone can influence the development of cultured neuroepithelial tumors through the presence of the specific receptor and suggest that this type of study applied to malignant neuroepithelial tumors is useful in obtaining more information on their biology and, perhaps, on new therapeutic strategies.
